Computed tomography dose optimisation in cystic fibrosis: A review.

Hdl Handle:
http://hdl.handle.net/10147/615157
Title:
Computed tomography dose optimisation in cystic fibrosis: A review.
Authors:
Ferris, Helena; Twomey, Maria; Moloney, Fiachra; O'Neill, Siobhan B; Murphy, Kevin; O'Connor, Owen J; Maher, Michael
Citation:
Computed tomography dose optimisation in cystic fibrosis: A review. 2016, 8 (4):331-41 World J Radiol
Publisher:
Baishideng Publishing Group Inc.
Journal:
World journal of radiology
Issue Date:
28-Apr-2016
URI:
http://hdl.handle.net/10147/615157
DOI:
10.4329/wjr.v8.i4.331
PubMed ID:
27158420
Abstract:
Cystic fibrosis (CF) is the most common autosomal recessive disease of the Caucasian population worldwide, with respiratory disease remaining the most relevant source of morbidity and mortality. Computed tomography (CT) is frequently used for monitoring disease complications and progression. Over the last fifteen years there has been a six-fold increase in the use of CT, which has lead to a growing concern in relation to cumulative radiation exposure. The challenge to the medical profession is to identify dose reduction strategies that meet acceptable image quality, but fulfil the requirements of a diagnostic quality CT. Dose-optimisation, particularly in CT, is essential as it reduces the chances of patients receiving cumulative radiation doses in excess of 100 mSv, a dose deemed significant by the United Nations Scientific Committee on the Effects of Atomic Radiation. This review article explores the current trends in imaging in CF with particular emphasis on new developments in dose optimisation.
Item Type:
Article
Language:
en
Keywords:
CYSTIC FIBROSIS; COMPUTED TOMOGRAPHY
ISSN:
1949-8470

Full metadata record

DC FieldValue Language
dc.contributor.authorFerris, Helenaen
dc.contributor.authorTwomey, Mariaen
dc.contributor.authorMoloney, Fiachraen
dc.contributor.authorO'Neill, Siobhan Ben
dc.contributor.authorMurphy, Kevinen
dc.contributor.authorO'Connor, Owen Jen
dc.contributor.authorMaher, Michaelen
dc.date.accessioned2016-06-30T15:28:03Z-
dc.date.available2016-06-30T15:28:03Z-
dc.date.issued2016-04-28-
dc.identifier.citationComputed tomography dose optimisation in cystic fibrosis: A review. 2016, 8 (4):331-41 World J Radiolen
dc.identifier.issn1949-8470-
dc.identifier.pmid27158420-
dc.identifier.doi10.4329/wjr.v8.i4.331-
dc.identifier.urihttp://hdl.handle.net/10147/615157-
dc.description.abstractCystic fibrosis (CF) is the most common autosomal recessive disease of the Caucasian population worldwide, with respiratory disease remaining the most relevant source of morbidity and mortality. Computed tomography (CT) is frequently used for monitoring disease complications and progression. Over the last fifteen years there has been a six-fold increase in the use of CT, which has lead to a growing concern in relation to cumulative radiation exposure. The challenge to the medical profession is to identify dose reduction strategies that meet acceptable image quality, but fulfil the requirements of a diagnostic quality CT. Dose-optimisation, particularly in CT, is essential as it reduces the chances of patients receiving cumulative radiation doses in excess of 100 mSv, a dose deemed significant by the United Nations Scientific Committee on the Effects of Atomic Radiation. This review article explores the current trends in imaging in CF with particular emphasis on new developments in dose optimisation.en
dc.language.isoenen
dc.publisherBaishideng Publishing Group Inc.en
dc.rightsArchived with thanks to World journal of radiologyen
dc.subjectCYSTIC FIBROSISen
dc.subjectCOMPUTED TOMOGRAPHYen
dc.titleComputed tomography dose optimisation in cystic fibrosis: A review.en
dc.typeArticleen
dc.identifier.journalWorld journal of radiologyen
dc.description.fundingNo fundingen
dc.description.provinceMunsteren
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.